Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04104841
Other study ID # MH117086
Secondary ID R34MH117086
Status Completed
Phase N/A
First received
Last updated
Start date August 7, 2018
Est. completion date July 11, 2022

Study information

Verified date December 2023
Source University of Maryland, College Park
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this study is to develop a modified behavioral activation program in adolescents with ADHD to be implemented by school mental health providers in an urban, low-income school district. Subsequently the investigators will examine its effectiveness in reducing depressive symptoms and improving emotion regulation and reward responsivity, compared to usual care.


Description:

Children with ADHD are at elevated risk for depression in adolescence and young adulthood, and this comorbidity is associated with far greater impairment than either disorder alone, including higher rates of inpatient hospitalization and increased risk for suicidal ideation and behavior. Despite these adverse outcomes, existing evidence-based interventions for ADHD have not demonstrated effects in reducing depressive symptoms nor do established depression prevention programs work as well for adolescents with ADHD. Reward responsivity (RR) and emotion regulation (ER) are two key factors demonstrated to mediate the association between ADHD and depression and are thus key targets for prevention. In an effort to address the gap between access and utilization of mental health care, which is especially stark among adolescents with ADHD, the investigators aim to develop and test a modified behavioral activation prevention program [Behaviorally Enhancing Adolescents' Mood in Schools (BEAM-S)] that incorporates modules to directly target these purported mechanisms. In line with the Deployment-Focused Model of Intervention Development and Testing, the investigators will develop a program that can be easily implemented and sustainable in the high school setting as delivered by school mental health staff that reduces depression and improves overall functioning in adolescents with ADHD, by way of improving RR and ER. As a first step, the investigators will conduct focus groups with community stakeholders (e.g., school mental health providers, school administration, adolescents, parents, teachers) to develop an acceptable and sustainable selected and indicated prevention program for school staff to utilize. The investigators will then initially train school staff to deliver this prevention program via to pilot the intervention for implementation of the prevention program in a case series to evaluate preliminary feasibility. The investigators will then conduct a stage 1 RCT with a hybrid-type 1 implementation effectiveness design in three high schools where adolescents will be randomized to either the BEAM-S condition (n= 54) or treatment as usual (n = 54). Finally, qualitative and quantitative data from aims 1-3 will be used to prepare final procedures for a future large-scale effectiveness trial R01 (aim 4).


Recruitment information / eligibility

Status Completed
Enrollment 50
Est. completion date July 11, 2022
Est. primary completion date July 1, 2021
Accepts healthy volunteers No
Gender All
Age group 14 Years to 18 Years
Eligibility Inclusion Criteria: - Enrolled in a participating Baltimore City Public High School - DSM-5 Diagnosis of attention-deficit/hyperactivity disorder (ADHD) - Depressive symptoms above T=65 on the Children's Depression Inventory (CDI) Exclusion Criteria: - History of seizures or neurological problems - DSM-diagnosis of Pervasive Developmental Disorder - Full scale IQ below 70 - Current depressive symptoms or active suicidality at severe levels where more intensive services would be warranted

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Behaviorally Enhancing Adolescents' Mood in Schools
8-session modified behavioral activation intervention
Usual Care
Referral to school mental health provider, social worker, or community care.

Locations

Country Name City State
United States University of Maryland College Park Maryland

Sponsors (2)

Lead Sponsor Collaborator
University of Maryland, College Park National Institute of Mental Health (NIMH)

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Children's Depression Inventory, 2nd Edition (CDI-2) Adolescent and parent reported depressive symptoms After the 8-week preventive intervention
Primary Children's Depression Inventory, 2nd Edition (CDI-2) Adolescent and parent reported depressive symptoms 4-week follow-up
Primary Children's Depression Inventory, 2nd Edition (CDI-2) Adolescent and parent reported depressive symptoms 12-week follow-up
Secondary Affective Reactivity Index Adolescent and parent reported irritability After the 8-week preventive intervention
Secondary Affective Reactivity Index Adolescent and parent reported irritability 4-week follow-up
Secondary Affective Reactivity Index Adolescent and parent reported irritability 12-week follow-up
Secondary Suicide Behavior Questionnaire Adolescent reported suicidal thoughts and behaviors After the 8-week preventive intervention
Secondary Suicide Behavior Questionnaire Adolescent reported suicidal thoughts and behaviors 4-week follow-up
Secondary Suicide Behavior Questionnaire Adolescent reported suicidal thoughts and behaviors 12-week follow-up
Secondary Emotion Regulation Checklist Parent reported emotion dysregulation After the 8-week preventive intervention
Secondary Emotion Regulation Checklist Parent reported emotion dysregulation 4-week follow-up
Secondary Emotion Regulation Checklist Parent reported emotion dysregulation 12-week follow-up
Secondary Difficulties in Emotion Regulation Adolescent reported emotion dysregulation After the 8-week preventive intervention
Secondary Difficulties in Emotion Regulation Adolescent reported emotion dysregulation 4-week follow-up
Secondary Difficulties in Emotion Regulation Adolescent reported emotion dysregulation 12-week follow-up
Secondary Mirror Tracing Persistence Task Emotion regulation behavioral task After the 8-week preventive intervention
Secondary Mirror Tracing Persistence Task Emotion regulation behavioral task 4-week follow-up
Secondary Mirror Tracing Persistence Task Emotion regulation behavioral task 12-week follow-up
Secondary Tripartite Pleasure Inventory Adolescent reported reward responsiveness After the 8-week preventive intervention
Secondary Tripartite Pleasure Inventory Adolescent reported reward responsiveness 4-week follow-up
Secondary Tripartite Pleasure Inventory Adolescent reported reward responsiveness 12-week follow-up
Secondary Reward Probability Index Measure of adolescent reported environmental reward After the 8-week preventive intervention
Secondary Reward Probability Index Measure of adolescent reported environmental reward 4-week follow-up
Secondary Reward Probability Index Measure of adolescent reported environmental reward 12-week follow-up
Secondary Behavioral Activation for Depression Scale Adolescent reported measure of behavioral activation and avoidance After the 8-week preventive intervention
Secondary Behavioral Activation for Depression Scale Adolescent reported measure of behavioral activation and avoidance 4-week follow-up
Secondary Behavioral Activation for Depression Scale Adolescent reported measure of behavioral activation and avoidance 12-week follow-up
Secondary Balloon Analog Risk Task Positive reinforcement After the 8-week preventive intervention
Secondary Balloon Analog Risk Task Positive reinforcement 4-week follow-up
Secondary Balloon Analog Risk Task Positive reinforcement 12-week follow-up
Secondary Impairment Rating Scale Parent- and teacher- report of global impairment After the 8-week preventive intervention
Secondary Impairment Rating Scale Parent- and teacher- report of global impairment 4-week follow-up
Secondary Impairment Rating Scale Parent- and teacher- report of global impairment 12-week follow-up
See also
  Status Clinical Trial Phase
Recruiting NCT06129396 - Effects of Aerobic Exercise Intervention in Adolescents With Attention-deficit/Hyperactivity Disorder (ADHD) N/A
Completed NCT04779333 - Lifestyle Enhancement for ADHD Program 2 N/A
Recruiting NCT05935722 - Evaluation of a Home-based Parenting Support Program: Parenting Young Children N/A
Completed NCT03148782 - Brain Plasticity Underlying Acquisition of New Organizational Skills in Children-R61 Phase N/A
Completed NCT04832737 - Strength-based Treatment Approach for Adults With ADHD N/A
Recruiting NCT04631042 - Developing Brain, Impulsivity and Compulsivity
Recruiting NCT05048043 - Development of a Game-supported Intervention N/A
Completed NCT03337646 - Evaluation of the Effect and Safety of Lisdexamfetamine in Children Aged 6-12 With ADHD and Autism Phase 4
Not yet recruiting NCT06080373 - Formulation-based CBT for Adult Inmates With ADHD: A Randomized Controlled Trial N/A
Not yet recruiting NCT06454604 - Virtual Reality Treatment for Emerging Adults With ADHD Phase 2
Not yet recruiting NCT06406309 - Settling Down for Sleep in ADHD: The Impact of Sensory and Arousal Systems on Sleep in ADHD N/A
Completed NCT02477280 - Effects of Expectation, Medication and Placebo on Objective and Self-rated Performance Phase 4
Completed NCT02911194 - a2 Milk for Autism and Attention-deficit Hyperactivity Disorder (ADHD) N/A
Completed NCT02555150 - A Comparison of PRC-063 and Lisdexamfetamine in the Driving Performance of Adults With ADHD Phase 3
Completed NCT02473185 - Effects of Expectation, Medication and Placebo on Objective and Self-rated Performance During the QbTest Phase 4
Completed NCT02780102 - Cognitive-Motor Rehabilitation, Stimulant Drugs, and Active Control in the Treatment of ADHD N/A
Completed NCT02829970 - Helping College Students With ADHD Lead Healthier Lifestyles N/A
Completed NCT02390791 - New Technologies to Help Manage ADHD N/A
Recruiting NCT04296604 - Transcranial Direct Current Stimulation (tDCS) Neuromodulation of Executive Function Across Neuropsychiatric Populations N/A
Recruiting NCT04175028 - Neuromodulation of Executive Function in the ADHD Brain N/A